Search Results for “ribociclib” – Endpoints News

SIGN UP

search results for: ribociclib

Novartis pauses enrollment for Kisqali breast cancer trials to align with nitrosamine guidelines

Last week

Theresa Heah enters the bat cave at Paratus; Eli Lilly exec takes CFO job at Jazz Pharmaceuticals

2 months ago

As Covid program advances, Enanta's new CMO says it's not 'limited to antivirals'; With all eyes on Gilead-partnered ...

Last year

Frederic Pla enlisted as COO at the Parker Institute; Former Alkermes exec named CMO at Seres Therapeutics

5 years ago

The class of 2017's winners and losers: A year of 'nonstop scientific achievements' raises troubling issues

7 years ago

Novartis’ Kisqali to go head-to-head with Pfizer’s Ibrance; USC joins regional biotech alliance

7 years ago

Novartis takes a $200M hit to write off a flop as execs spell out a cautious R&D strategy

7 years ago

Best in class? Eli Lilly claims a lead role awaits its CDK 4/6 drug abemaciclib after PhIII success

8 years ago

That turnaround on new FDA drug approvals? We’re right on schedule

8 years ago

Laggard Lilly says its CDK 4/6 drug abemaciclib scored in PhIII, while rivals at Novartis, Pfizer sharpen their ...

8 years ago

Watch out Pfizer, Novartis’ LEE011 bags quick OK for frontline use against breast cancer

8 years ago

Novartis’s blockbuster CDK 4/6 contender LEE011 gets a VIP countdown at the FDA

8 years ago

Novartis promises a speedy CAR-T pitch, boasts about its slate of blockbusters-to-be

8 years ago

Novartis heads to the finish line with CDK 4/6 blockbuster contender ribociclib

8 years ago

Frustrated Eli Lilly may have to settle for a lonely last-place finish in the blockbuster CDK 4/6 race

8 years ago

Novartis’ star cancer drug lands on an inside FDA track, racing Lilly to a showdown with Pfizer

8 years ago

The 15 top R&D spenders in the global biopharma business: 2016

8 years ago

latest

Most read

Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D

17 hours ago

Novartis brings Lutathera to adolescents with rare cancer in first for radioligand class

9 hours ago

FDA gives accelerated approval to Day One’s targeted treatment for most common brain tumor in kids

9 hours ago

Inizio Evoke Comms taps Stephanie DeViteri in return to agency as president

10 hours ago

Vertex licenses TreeFrog’s tech to upscale cell therapy manufacturing for diabetes candidates

10 hours ago

see latest stream